Literature DB >> 25759245

Sex-specific patterns and deregulation of endocrine pathways in the gene expression profiles of Bangladeshi adults exposed to arsenic contaminated drinking water.

Alexandra Muñoz1, Yana Chervona1, Megan Hall2, Thomas Kluz1, Mary V Gamble3, Max Costa4.   

Abstract

Arsenic contamination of drinking water occurs globally and is associated with numerous diseases including skin, lung and bladder cancers, and cardiovascular disease. Recent research indicates that arsenic may be an endocrine disruptor. This study was conducted to evaluate the nature of gene expression changes among males and females exposed to arsenic contaminated water in Bangladesh at high and low doses. Twenty-nine (55% male) Bangladeshi adults with water arsenic exposure ranging from 50 to 1000 μg/L were selected from the Folic Acid Creatinine Trial. RNA was extracted from peripheral blood mononuclear cells for gene expression profiling using Affymetrix 1.0 ST arrays. Differentially expressed genes were assessed between high and low exposure groups for males and females separately and findings were validated using quantitative real-time PCR. There were 534 and 645 differentially expressed genes (p<0.05) in the peripheral blood mononuclear cells of males and females, respectively, when high and low water arsenic exposure groups were compared. Only 43 genes overlapped between the two sexes, with 29 changing in opposite directions. Despite the difference in gene sets both males and females exhibited common biological changes including deregulation of 17β-hydroxysteroid dehydrogenase enzymes, deregulation of genes downstream of Sp1 (specificity protein 1) transcription factor, and prediction of estrogen receptor alpha as a key hub in cardiovascular networks. Arsenic-exposed adults exhibit sex-specific gene expression profiles that implicate involvement of the endocrine system. Due to arsenic's possible role as an endocrine disruptor, exposure thresholds for arsenic may require different parameters for males and females.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Arsenic; Cardiovascular disease; HSD17B-1; Humans

Mesh:

Substances:

Year:  2015        PMID: 25759245      PMCID: PMC4410068          DOI: 10.1016/j.taap.2015.02.025

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  55 in total

1.  Global functional profiling of gene expression.

Authors:  Sorin Draghici; Purvesh Khatri; Rui P Martins; G Charles Ostermeier; Stephen A Krawetz
Journal:  Genomics       Date:  2003-02       Impact factor: 5.736

2.  Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan.

Authors:  Chin-Hsiao Tseng; Choon-Khim Chong; Ching-Ping Tseng; Yu-Mei Hsueh; Hung-Yi Chiou; Ching-Chung Tseng; Chien-Jen Chen
Journal:  Toxicol Lett       Date:  2003-01-31       Impact factor: 4.372

3.  Functional synergy between the transcription factor Sp1 and the estrogen receptor.

Authors:  W Porter; B Saville; D Hoivik; S Safe
Journal:  Mol Endocrinol       Date:  1997-10

4.  Cancer incidence and pattern of arsenic concentration in drinking water wells in Córdoba, Argentina.

Authors:  Laura Rosana Aballay; María del Pilar Díaz; Franco Matías Francisca; Sonia Edith Muñoz
Journal:  Int J Environ Health Res       Date:  2011-10-24       Impact factor: 3.411

5.  Arsenic disruption of steroid receptor gene activation: Complex dose-response effects are shared by several steroid receptors.

Authors:  Jack E Bodwell; Julie A Gosse; Athena P Nomikos; Joshua W Hamilton
Journal:  Chem Res Toxicol       Date:  2006-12       Impact factor: 3.739

6.  Gene expression profiles in peripheral lymphocytes by arsenic exposure and skin lesion status in a Bangladeshi population.

Authors:  Maria Argos; Muhammad G Kibriya; Faruque Parvez; Farzana Jasmine; Muhammad Rakibuz-Zaman; Habibul Ahsan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-07       Impact factor: 4.254

7.  Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.

Authors:  Michael P Waalkes; Jerrold M Ward; Jie Liu; Bhalchandra A Diwan
Journal:  Toxicol Appl Pharmacol       Date:  2003-01-01       Impact factor: 4.219

Review 8.  Effects of arsenic exposure on DNA methylation and epigenetic gene regulation.

Authors:  John F Reichard; Alvaro Puga
Journal:  Epigenomics       Date:  2010-02       Impact factor: 4.778

9.  Associations between arsenic exposure and global posttranslational histone modifications among adults in Bangladesh.

Authors:  Yana Chervona; Megan N Hall; Adriana Arita; Fen Wu; Hong Sun; Hsiang-Chi Tseng; Eunus Ali; Mohammad Nasir Uddin; Xinhua Liu; Maria Antonietta Zoroddu; Mary V Gamble; Max Costa
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-12       Impact factor: 4.254

10.  Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action.

Authors:  Kuladip Jana; Subarna Jana; Prabhat Kumar Samanta
Journal:  Reprod Biol Endocrinol       Date:  2006-02-16       Impact factor: 5.211

View more
  8 in total

1.  KRAS-retroviral fusion transcripts and gene amplification in arsenic-transformed, human prostate CAsE-PE cancer cells.

Authors:  B Alex Merrick; Dhiral P Phadke; Meredith A Bostrom; Ruchir R Shah; Garron M Wright; Xinguo Wang; Oksana Gordon; Katherine E Pelch; Scott S Auerbach; Richard S Paules; Michael J DeVito; Michael P Waalkes; Erik J Tokar
Journal:  Toxicol Appl Pharmacol       Date:  2020-04-25       Impact factor: 4.219

2.  Arsenic exposure from drinking water and endothelial dysfunction in Bangladeshi adolescents.

Authors:  Shohreh F Farzan; Hem Mahbubul Eunus; Syed Emdadul Haque; Golam Sarwar; Akm Rabiul Hasan; Fen Wu; Tariqul Islam; Alauddin Ahmed; Mohammad Shahriar; Farzana Jasmine; Muhammad G Kibriya; Faruque Parvez; Margaret R Karagas; Yu Chen; Habibul Ahsan
Journal:  Environ Res       Date:  2022-01-08       Impact factor: 6.498

Review 3.  Epigenetics of breast cancer: Modifying role of environmental and bioactive food compounds.

Authors:  Donato F Romagnolo; Kevin D Daniels; Jonathan T Grunwald; Stephan A Ramos; Catherine R Propper; Ornella I Selmin
Journal:  Mol Nutr Food Res       Date:  2016-06       Impact factor: 5.914

Review 4.  An approach to classifying occupational exposures to endocrine disrupting chemicals by sex hormone function using an expert judgment process.

Authors:  R Prichystalova; E Caron-Beaudoin; L Richardson; E Dirkx; A Amadou; T Zavodna; R Cihak; V Cogliano; J Hynes; L Pelland-St-Pierre; M A Verner; M van Tongeren; V Ho
Journal:  J Expo Sci Environ Epidemiol       Date:  2020-07-23       Impact factor: 5.563

5.  Endocrine Disruptors Induced Distinct Expression of Thyroid and Estrogen Receptors in Rat versus Mouse Primary Cerebellar Cell Cultures.

Authors:  Gergely Jocsak; Eniko Ioja; David Sandor Kiss; Istvan Toth; Zoltan Barany; Tibor Bartha; Laszlo V Frenyo; Attila Zsarnovszky
Journal:  Brain Sci       Date:  2019-12-05

6.  Association between Arsenic Level, Gene Expression in Asian Population, and In Vitro Carcinogenic Bladder Tumor.

Authors:  Sonalika Singhal; Nathan A Ruprecht; Donald Sens; Kouhyar Tavakolian; Kevin L Gardner; Sandeep K Singhal
Journal:  Oxid Med Cell Longev       Date:  2022-01-07       Impact factor: 7.310

7.  Identification of gene expression predictors of occupational benzene exposure.

Authors:  Courtney Schiffman; Cliona M McHale; Alan E Hubbard; Luoping Zhang; Reuben Thomas; Roel Vermeulen; Guilan Li; Min Shen; Stephen M Rappaport; Songnian Yin; Qing Lan; Martyn T Smith; Nathaniel Rothman
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

8.  Arsenic‑induced BRCA1 CpG promoter methylation is associated with the downregulation of ERα and resistance to tamoxifen in MCF7 breast cancer cells and mouse mammary tumor xenografts.

Authors:  Ornella I Selmin; Micah G Donovan; Bethany Skovan; Gillian D Paine-Murieta; Donato F Romagnolo
Journal:  Int J Oncol       Date:  2019-01-15       Impact factor: 5.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.